A study showed that the expression of TSP-1 and CD47 is increased in human malignant melanoma tumor tissue, and targeting the TSP-1/CD47 pathway may preserve CD8+ T-cell activation, proliferation, and bioenergetics to alleviate the tumor burden (83). This evidence concerns the gene THBS1 and neoplasm.